​

CONMED (CNMD) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

CNMD Stock Forecast

CONMED (CNMD) stock forecast, based on 18 Wall Street analysts, predicts a 12-month average price target of $61.00, with a high of $61.00 and a low of $61.00. This represents a 10.97% increase from the last price of $54.97.

$50 $62 $74 $86 $98 $110 High: $61 Avg: $61 Low: $61 Last Closed Price: $54.97

CNMD Stock Rating

CONMED stock's rating consensus is Buy, based on 18 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 9 Buy (50.00%), 9 Hold (50.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 18 0 9 9 Strong Sell Sell Hold Buy Strong Buy

CNMD Price Target Upside V Benchmarks

TypeNameUpside
StockCONMED10.97%
SectorHealthcare Stocks 23.68%
IndustryMedical Device Stocks16.34%

Price Target Trends

1M3M12M
# Anlaysts-12
Avg Price Target-$61.00$79.00
Last Closing Price$54.97$54.97$54.97
Upside/Downside-10.97%43.71%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 252-4--6
May, 252-5--7
Apr, 25214--7
Mar, 25214--7
Feb, 25313--7
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
May 01, 2025Mike MatsonNeedham$61.00$57.196.66%10.97%
Oct 04, 2024Mike MatsonNeedham$97.00$66.5945.67%76.46%
Apr 25, 2024Matt O\'BrienPiper Sandler$95.00$64.3447.65%72.82%
Apr 25, 2024Mike MatsonNeedham$107.00$70.0152.84%94.65%
Oct 26, 2022Matt O'BrienPiper Sandler$108.00$83.3929.51%96.47%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
May 01, 2025NeedhamBuyBuyhold
Oct 04, 2024Piper SandlerUnderperformUnderperformhold
Oct 04, 2024NeedhamBuyBuyhold
Aug 01, 2024Wells FargoBuyBuyhold
Apr 25, 2024Piper SandlerOverweightOverweighthold
Apr 25, 2024NeedhamBuyBuyhold
Feb 01, 2024Wells FargoEqual-WeightEqual-Weighthold
Feb 01, 2024NeedhamBuyBuyhold
Apr 27, 2023NeedhamBuyBuyhold
Mar 27, 2023KeyBancOverweightupgrade

Financial Forecast

EPS Forecast

$-3 $-2 $-1 $0 $1 $2 $3 $4 $5 $6 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$0.33$2.14$-2.68$2.10$4.29---
Avg Forecast$2.10$3.17$3.12$3.50$4.03$4.74$5.63$5.58
High Forecast$2.13$3.21$3.15$3.55$4.04$5.02$5.85$5.65
Low Forecast$2.06$3.12$3.08$3.49$4.00$4.50$5.40$5.46
Surprise %-84.29%-32.49%-185.90%-40.00%6.45%---

Revenue Forecast

$850M $1B $1B $1B $1B $2B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$862.46M$1.01B$1.05B$1.24B$1.31B---
Avg Forecast$872.65M$1.01B$1.10B$1.25B$1.30B$1.40B$1.50B$1.54B
High Forecast$881.40M$1.02B$1.10B$1.26B$1.32B$1.41B$1.50B$1.56B
Low Forecast$860.85M$998.88M$1.09B$1.23B$1.28B$1.38B$1.50B$1.52B
Surprise %-1.17%-0.19%-4.71%-0.42%0.38%---

Net Income Forecast

$-200M $-120M $-40M $40M $120M $200M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$9.52M$62.54M$-80.58M$64.46M$132.42M---
Avg Forecast$-9.36M$54.97M$-111.81M$64.46M$126.72M$150.14M$177.49M$176.04M
High Forecast$7.77M$65.96M$-67.76M$90.54M$127.35M$158.40M$184.69M$178.33M
Low Forecast$-26.49M$43.98M$-155.87M$38.38M$126.09M$141.89M$170.29M$172.31M
Surprise %-201.64%13.78%-27.93%-4.50%---

CNMD Forecast FAQ

Is CONMED stock a buy?

CONMED stock has a consensus rating of Buy, based on 18 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 9 Buy, 9 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that CONMED is a favorable investment for most analysts.

What is CONMED's price target?

CONMED's price target, set by 18 Wall Street analysts, averages $61 over the next 12 months. The price target range spans from $61 at the low end to $61 at the high end, suggesting a potential 10.97% change from the previous closing price of $54.97.

How does CONMED stock forecast compare to its benchmarks?

CONMED's stock forecast shows a 10.97% upside, underperforming the average forecast for the healthcare stocks sector (23.68%) and underperforming the medical device stocks industry (16.34%).

What is the breakdown of analyst ratings for CONMED over the past three months?

  • June 2025: 33.33% Strong Buy, 0% Buy, 66.67% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 28.57% Strong Buy, 0% Buy, 71.43% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 28.57% Strong Buy, 14.29% Buy, 57.14% Hold, 0% Sell, 0% Strong Sell.

What is CONMED’s EPS forecast?

CONMED's average annual EPS forecast for its fiscal year ending in December 2025 is $4.74, marking a 10.49% increase from the reported $4.29 in 2024. Estimates for the following years are $5.63 in 2026, and $5.58 in 2027.

What is CONMED’s revenue forecast?

CONMED's average annual revenue forecast for its fiscal year ending in December 2025 is $1.4B, reflecting a 6.79% increase from the reported $1.31B in 2024. The forecast for 2026 is $1.5B, and $1.54B for 2027.

What is CONMED’s net income forecast?

CONMED's net income forecast for the fiscal year ending in December 2025 stands at $150.14M, representing an 13.38% increase from the reported $132.42M in 2024. Projections indicate $177.49M in 2026, and $176.04M in 2027.